Technical Analysis for AQST - Aquestive Therapeutics, Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Shooting Star Candlestick | Bearish | -5.77% | |
| MACD Bullish Signal Line Cross | Bullish | -5.77% | |
| Pocket Pivot | Bullish Swing Setup | -5.77% | |
| Volume Surge | Other | -5.77% | |
| Doji - Bearish? | Reversal | -5.77% | |
| Up 3 Days in a Row | Strength | -5.77% | |
| Slingshot Bearish | Bearish Swing Setup | -5.41% | |
| Oversold Stochastic | Weakness | -5.41% | |
| Lower Bollinger Band Walk | Weakness | 1.24% | |
| Lower Bollinger Band Touch | Weakness | 1.24% |
| Alert | Time |
|---|---|
| Down 5% | about 6 hours ago |
| Down 3% | about 6 hours ago |
| Shooting Star Candlestick Entry | about 6 hours ago |
| Fell Below Previous Day's Low | about 6 hours ago |
| Down 2 % | about 6 hours ago |
Get this analysis on your stocks daily!
- Earnings date: 08/05/2024
Aquestive Therapeutics, Inc. Description
Aquestive Therapeutics, Inc. is a specialty pharmaceutical company. The Company is focused on the development of treatments for diseases related to the central nervous system (CNS). Its CNS programs consist of a pipeline of products that include Libervant, Sympazan, and AQST-117. Libervant is a buccal soluble film formulation of diazepam for the treatment of recurrent epileptic seizures. Sympazan is an oral soluble film formulation of clobazam for the treatment of seizures associated with a rare, intractable form of epilepsy known as Lennox-Gastaut Syndrome. AQST-117 is an oral soluble film formulation of riluzole for the treatment of Amyotrophic Lateral Sclerosis. The Company’s complex molecule programs consist of AQST-108, and AQST-305, for the treatment of anaphylaxis and neuroendocrine tumors respectively. The Company also has a pipeline of products under partner programs, which includes Suboxone and APL-130277 for the treatment of opioid dependence, and Parkinson’s disease.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Pharmaceutical Disease Drugs Psychoactive Drugs Opioids Epilepsy Amyotrophic Lateral Sclerosis Chloroarenes Seizure Gabaa Receptor Positive Allosteric Modulators Neuroendocrine Tumors Neuroendocrine Tumor Parkinson’s Disease Anaphylaxis Riluzole
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 6.23 |
| 52 Week Low | 1.2514 |
| Average Volume | 1,847,557 |
| 200-Day Moving Average | 2.73 |
| 50-Day Moving Average | 3.11 |
| 20-Day Moving Average | 2.68 |
| 10-Day Moving Average | 2.53 |
| Average True Range | 0.19 |
| RSI (14) | 36.71 |
| ADX | 35.52 |
| +DI | 16.24 |
| -DI | 35.93 |
| Chandelier Exit (Long, 3 ATRs) | 2.54 |
| Chandelier Exit (Short, 3 ATRs) | 2.80 |
| Upper Bollinger Bands | 3.05 |
| Lower Bollinger Band | 2.31 |
| Percent B (%b) | 0.19 |
| BandWidth | 27.76 |
| MACD Line | -0.18 |
| MACD Signal Line | -0.20 |
| MACD Histogram | 0.0115 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 2.89 | ||||
| Resistance 3 (R3) | 2.90 | 2.76 | 2.81 | ||
| Resistance 2 (R2) | 2.76 | 2.65 | 2.76 | 2.79 | |
| Resistance 1 (R1) | 2.61 | 2.58 | 2.54 | 2.60 | 2.76 |
| Pivot Point | 2.47 | 2.47 | 2.44 | 2.47 | 2.47 |
| Support 1 (S1) | 2.32 | 2.36 | 2.25 | 2.31 | 2.14 |
| Support 2 (S2) | 2.18 | 2.29 | 2.18 | 2.11 | |
| Support 3 (S3) | 2.03 | 2.18 | 2.09 | ||
| Support 4 (S4) | 2.02 |
